Influenza Market is expected to reach USD 10.59 billion by 2023
The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new inf
(EMAILWIRE.COM, December 11, 2018 ) Influenza Market Overview
Influenza or flu is a transmittable respiratory disease which affects nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be seasonal, pandemic, or zoonotic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache.
Request for Sample @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries is not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Influenza Market Forecast Report (2018-2023)
Global Influenza Market is expected to reach USD 10.59 billion by 2023 from USD 7.03 billion in 2018, growing at a CAGR of 8.54% during the forecast period, 2018-2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Influenza Market Segmentation
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major Influenza market share of 50% in 2018.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-influenza-market-1704/
Major Players:
The major companies dominating this market for its products and services are
Sanofi-Pasteur (U.S.),
AstraZeneca (United Kingdom),
F. Hoffmann-La Roche (Switzerland),
Novartis (Switzerland),
GlaxoSmithKline (U.K.),
Pfizer Inc. (U.S.),
Merck & Co. (U.S.),
Abbott Laboratories (U.S.),
Mitsubishi Tanabe Pharma Corporation (Japan),
CSL Limited (Australia).
Customize Report @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/customize-report
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Influenza or flu is a transmittable respiratory disease which affects nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be seasonal, pandemic, or zoonotic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache.
Request for Sample @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries is not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Influenza Market Forecast Report (2018-2023)
Global Influenza Market is expected to reach USD 10.59 billion by 2023 from USD 7.03 billion in 2018, growing at a CAGR of 8.54% during the forecast period, 2018-2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Influenza Market Segmentation
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major Influenza market share of 50% in 2018.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-influenza-market-1704/
Major Players:
The major companies dominating this market for its products and services are
Sanofi-Pasteur (U.S.),
AstraZeneca (United Kingdom),
F. Hoffmann-La Roche (Switzerland),
Novartis (Switzerland),
GlaxoSmithKline (U.K.),
Pfizer Inc. (U.S.),
Merck & Co. (U.S.),
Abbott Laboratories (U.S.),
Mitsubishi Tanabe Pharma Corporation (Japan),
CSL Limited (Australia).
Customize Report @ https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/customize-report
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results